Pfizer's stock surged after CEO Albert Bourla announces an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty. ...

Welcome back. President Trump vowing to impose a 100% tariff on pharmaceutical companies unless the company agrees to build a manufacturing plant here in the United States. The threatened tariffs said to go into effect on October 1st.John Flavin, Portal Innovations founder and CEO joins us now. Investor in and early stage biotech companies. John, how does this affect your world.Well, I mean, if you step back, uh, before a drug becomes a drug, um, it starts in a lab, usually at a research university, um, and ...